LifeNuclear, a healthcare technology startup founded by Dr. Remo George at the University of Alabama at Birmingham, is developing a digital platform called TheraGuide to simplify post-treatment instructions for patients receiving radiopharmaceutical cancer therapies. The platform aims to transform complex written guidance into clear, accessible, and interactive support to help patients and caregivers understand radiation safety. LifeNuclear has made significant progress, including a licensing agreement with UAB and the deployment of TheraGuide for beta evaluation through Apple's TestFlight. The company plans to refine the platform based on feedback from clinical partners and hopes to enhance patient confidence and safety as radiopharmaceutical therapies become more common.
Fri, 07 Aug 2026 17:34:09 GMT | The University of Alabama at Birmingham